ValiRx Share Price | |
---|---|
Price | 3.80 |
Bid | 3.70 |
Ask | 3.90 |
Change | 0.125 (3.40%) |
Volume | 789,189 |
Open | 3.60 |
High | 3.80 |
Low | 3.60 |
Prev. Close | 3.675 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 132.35m |
Market Capitalisation | £5.03m |
Market Size | 15,000 |
52 Week High | 14.75 |
52 Week High Date | 03-Nov-2023 |
52 Week Low | 3.55 |
52 Week Low Date | 14-Mar-2024 |
# Trades | 19 |
---|---|
Vol. Sold | 673 |
Sold Value | £N/A |
Vol. Bought | 788,516 |
Bought Value | £29.33k |
PE Ratio | -1.24183 |
Earnings | -3.06 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
19-Mar-24 | 11:52:00 | 3.725 | 673 | Sell* | 3.70 | 3.90 | 25.07 | O Ordinary |
19-Mar-24 | 10:28:16 | 3.815 | 20,000 | Buy* | 3.70 | 3.90 | 763.00 | O Ordinary |
19-Mar-24 | 10:08:12 | 3.815 | 20,000 | Buy* | 3.70 | 3.90 | 763.00 | O Ordinary |
19-Mar-24 | 09:08:10 | 3.815 | 272 | Buy* | 3.70 | 3.90 | 10.38 | O Ordinary |
19-Mar-24 | 09:07:19 | 3.8888 | 6,428 | Buy* | 3.70 | 3.90 | 249.97 | O Ordinary |
19-Mar-24 | 09:01:46 | 3.89 | 10,000 | Buy* | 3.70 | 3.90 | 389.00 | O Ordinary |
19-Mar-24 | 08:56:10 | 3.80 | 25,000 | Buy* | 3.70 | 3.80 | 950.00 | O Ordinary |
19-Mar-24 | 08:54:52 | 3.90 | 75,000 | Buy* | 3.70 | 3.80 | 2,925 | O Ordinary Non protected portfolio Single protected transaction |
19-Mar-24 | 08:54:45 | 3.77 | 20,000 | Buy* | 3.70 | 3.80 | 754.00 | O Ordinary |
19-Mar-24 | 08:52:37 | 3.775 | 25,000 | Buy* | 3.60 | 3.80 | 943.75 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Jul-22 | 07-Jul-22 | Placing | Gerald Desler held the position of CFO at the time of this trade.Gerald Desler | 10.00 | GBX | 25,000 | 128,668 |
07-Jul-22 | 07-Jul-22 | Placing | Kevin Cox held the position of Non-Executive Chairman at the time of this trade.Kevin Cox | 10.00 | GBX | 100,000 | 372,333 |
07-Jul-22 | 07-Jul-22 | Placing | Martin Lampshire held the position of Non-Executive Director at the time of this trade.Martin Lampshire | 10.00 | GBX | 100,000 | 144,000 |
07-Jul-22 | 07-Jul-22 | Placing | Suzanne Dilly held the position of CEO at the time of this trade.Suzanne Dilly | 10.00 | GBX | 100,000 | 416,668 |
18-Feb-21 | 17-Feb-21 | Buy | Kevin Cox held the position of Non-Executive Chairman at the time of this trade.Kevin Cox | 22.25 | GBX | 22,000 | 272,333 |
Click here to read more about our shareholder information - providing intellectual, corporate and financial support in the early stages of drug development.